Furneri, G., Santoni, L., Ricella, C., & Prosperini, L. (2019). Cost-effectiveness analysis of escalating to natalizumab or switching among immunomodulators in relapsing-remitting multiple sclerosis in Italy. BMC Health Serv Res.
Citação norma ChicagoFurneri, Gianluca, Laura Santoni, Chiara Ricella, and Luca Prosperini. "Cost-effectiveness Analysis of Escalating to Natalizumab or Switching Among Immunomodulators in Relapsing-remitting Multiple Sclerosis in Italy." BMC Health Serv Res 2019.
MLA CitationFurneri, Gianluca, Laura Santoni, Chiara Ricella, and Luca Prosperini. "Cost-effectiveness Analysis of Escalating to Natalizumab or Switching Among Immunomodulators in Relapsing-remitting Multiple Sclerosis in Italy." BMC Health Serv Res 2019.